Published date: 19 March 2021

Closed opportunity - This means that the contract is currently closed. The buying department may be considering suppliers that have already applied, or no suitable offers were made.


Closing: 13 April 2021, 5pm

Contract summary

Industry

  • Medical consumables - 33140000

  • Other therapeutic products - 33693000

  • Repair and maintenance services of medical equipment - 50421000

Location of contract

Any region

Value of contract

£3,606,000

Procurement reference

tender_234923/932536

Published date

19 March 2021

Closing date

13 April 2021

Closing time

5pm

Contract start date

1 August 2021

Contract end date

31 July 2023

Contract type

Supply contract

Procedure type

Open procedure (above threshold)

Any interested supplier may submit a tender in response to an opportunity notice.

This procedure can be used for procurements above the relevant contract value threshold.

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

No

Description

The Therapeutic Apheresis Services (TAS) function operates within the Clinical Services directorate of NHSBT. Multi-disciplinary TAS teams operate from eight regional hub units and three 3 spoke sites that are based within Acute NHS Trusts across England and South Wales. Each unit provides a portfolio of therapeutic treatments to both adult and paediatric patients from across a range of clinical specialities. Included in the TAS portfolio of therapeutic procedures is Extracorporeal Photopheresis (ECP) which is provided from four of the TAS hub units (Bristol, London, Oxford, and Manchester) as well as all three of the spoke sites (the Clatterbridge Cancer Centre, Cardiff and The Vale Health Board and Plymouth University Hospitals Trust). The ECP system's utilised by the TAS teams are able to perform both adult and paediatric procedures and have an integral clinical grade light box.
The requirement for this procurement is to source machine consumables and maintenance services to support existing Extracorporeal Photopheresis machine platforms.
This Framework Agreement is for a period of 2 years with two 1-year options to extend. It is the intension of NHSBT to award a Framework Agreement for these requirements by August 2021. The following contracting authorities will be able to purchase against the Framework Agreement: any NHS Authority or Trust and Scottish National Blood Transfusion Service.

About the buyer

Address

500 North Bristol Park
Bristol
BS43 7QH
England

Email

marta.drozdzowska@nhsbt.nhs.uk